Protagen Employs UNIarray Platform to Detect Protein Biomarkers Associated with Infectious Disease | GenomeWeb

German biotech companies Protagen and Mikrogen said this week that they are collaborating on the discovery of autoantibody signatures associated with infectious diseases.

The collaboration will use Protagen's UNIarray protein array platform to detect specific autoantibody signatures in serum.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.